nivolumab
bms
['nivolumab', 'nivo']
a clinical trial led by our dr. isabella claudia glitza (abstract 9554) demonstrated the feasibility of intrathecal and intravenous nivolumab for patients with leptomeningeal disease. #asco23 #endcancer (8/9) 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789